SUMMARY
Spinal anaesthesia is a popular procedure for caesarean section. However, without prophylactic therapy, hypotension occurs frequently (in up to 80% of patients) [1] [2] [3] . Even short periods of maternal hypotension have been shown to produce changes in the acid-base status of neonates, despite prompt treatment 4, 5 . Ephedrine is commonly used in the treatment of hypotension during spinal anaesthesia. It causes pronounced stimulation of beta receptors and stimulation of alpha receptors, increasing systolic and diastolic arterial pressure and heart rate, while not leading to significant uterine vasoconstriction because it has minimal alpha-adrenergic activity in the uterine vasculature 6, 7 . Some studies have reported a high incidence of hypotension during caesarean section, despite the use of high doses of IV ephedrine in an attempt to prevent hypotension. Therefore there is no consensus as to the optimum dosage and timing of administration of ephedrine 8, 9 . Mild to moderate reduction in maternal blood pressure may have a profound effect on uterine blood flow, causing fetal bradycardia, hypoxia, acidosis and neonatal depression 10, 11 . Although umbilical blood gases may reflect the metabolic status of the fetus and predict early neonatal consequences, it has been found that lactic acidosis is a better indicator of neonatal asphyxia than pH and blood gases 11, 12 . The purpose of the present study was to evaluate the incidence of maternal hypotension and the fetal blood gases and lactate levels from cord samples, in women given either infusion or bolus administration of ephedrine to prevent hypotension during spinal anaesthesia for elective caesarean delivery.
MATERIALS AND METHODS
Approval for this study was obtained from the Ethics Committee of our hospital. After acquiring informed consent, we studied 30 healthy parturients at term gestation undergoing elective caesarean section. Exclusion criteria included active labour, rupture of amnionic membranes, chronic or pregnancy-induced hypertension, insulin-dependent diabetes mellitus, multiple gestation, oligohydramnios and the preoperative diagnosis of "small for gestational age" fetus.
After entering the operating theatre, baseline maternal blood pressure and heart rate values were calculated using the arithmetical mean value for three consecutive non-invasive oscillometric measurements (Accutor) obtained at one-minute intervals prior to intravenous hydration. Haemodynamic measurements were repeated throughout the period of delivery at the same intervals. Oxygen 3 l/min was administered using a nasal cannula before induction of spinal anaesthesia and was continued throughout the period of delivery.
After the patient was placed in the left lateral position, lactated Ringer's solution was infused intravenously at 20 ml.kg -1 and then continued at 9 ml.h -1 in both groups. Spinal anaesthesia was induced with the patient in the sitting position. A 25 gauge Sprotte spinal needle was introduced through a 20 gauge introducer into the subarachnoid space at either the L2-3 or L3-4 interspace. According to the height of the patient, 10.5 to 13.5 mg of 0.5% hyperbaric bupivacaine was administered. The dermatomal level of sensory loss was determined by pinprick. Patients were randomly allocated into one of two study groups using the method of sealed envelopes. In the infusion group (Group I, n=15), ephedrine was infused at the rate of 5 mg.min -1 after spinal injection. Infusion solutions were prepared by adding 50 mg of ephedrine to 50 ml of normal saline. Infusions were initiated using a syringe pump (SP-500, JMSCo., Ltd, Hiroshima, Japan). In the bolus group (Group B, n=15), ephedrine 10 mg was administered as IV bolus in the case of development of hypotension (which was defined as a 20% decrease from the baseline level measured prior to fluid preload). If the systolic arterial blood pressure was not restored, the procedure was repeated every two minutes.
After the Group 1 patients were brought back into the left modified supine position, following spinal injection, ephedrine infusion 5 mg.min -1 was commenced. The infusion was adjusted by measurements of blood pressure at one-minute intervals. If hypotension lasting longer than two minutes was observed despite ephedrine infusion, 10 mg of ephedrine was administered as an IV bolus. If the systolic blood pressure exceeded 100-110% of baseline measurements, the infusion dosage was reduced to half and if the systolic blood pressure exceeded 120% of baseline measurements, the infusion was ceased.
Episodes of maternal nausea and/or vomiting were recorded until the termination of the operation.
The maternal radial artery was punctured in order to obtain samples for blood gas analysis, just at the moment of delivery. The time from insertion of the spinal needle to delivery (I-D) and the time from uterine incision to delivery (U-D) were also recorded.
Neonatal wellbeing at delivery was assessed by a paediatrician using Apgar scores at one and five minutes. In addition, umbilical arterial and venous blood samples were analysed (Blood Gas System, Stat Profile 5, Nova Biomedical, U.S.A.) to assess neonatal acid-base status (including analysis for lactate levels). The blood pressure of the neonate was measured just after the moment of delivery and at 15 minutes after delivery using the automatic oscillometric technique (Accutor). The heart rate was recorded using a stethoscope for a period of 15 minutes.
All data were expressed as mean±standard deviation. Differences between groups were evaluated using Student's t test and Mann-Whitney U test, and the incidence of nausea and vomiting was compared using Fisher's exact test. For haemodynamic changes within the groups, analysis of variance (one-way ANOVA) was performed. A P value of <0.05 was accepted as statistically significant.
RESULTS
There were no significant differences between the groups in relation to demographics or intraoperative crystalloid administration, I-D time, U-D time, baseline systolic blood pressure or baseline heart rate (P>0.05, Table 1 In Group I, no differences were noted in comparing the systolic arterial blood pressure to baseline (P>0.05), whereas in Group B, a significant decrease in systolic arterial blood pressure, which was limited to the period between the second and fifth minutes, was found (P<0.05, Figure 1 ). The baseline systolic arterial blood pressure did not exceed 140 mmHg in any patient. Bolus ephedrine injection was not required in any patient in Group I. In group B, 13 patients received bolus ephedrine administration (P>0.05). One patient in Group B required the administration of four doses (40 mg) of ephedrine. Except for one patient in the Group B, none of the patients had a systolic pressure lower than 100 mmHg for more than three minutes.
The heart rate fluctuated, with a tendency to increase in both groups. In both groups, the heart rate increased when compared to the baseline levels from the second to tenth minutes except at the sixth minute in the infusion group (P<0.05). However, no significant difference in increase in heart rate was detected between the groups (P>0.05, Figure 2 ). Nausea was observed in one patient in Group I (6%), whereas nausea and vomiting was observed in 10 patients in group B (66%) (P<0.05). There were no significant differences between the groups with respect to pH, P a CO 2 , P a O 2 , base excess and maternal lactate levels (P>0.05, Table 2 ).
Analysis of the data for all neonates showed that, except for the neonate in Group B with a first minute Apgar score of 1, no neonate had an Apgar score of less than 7 at one minute or an Apgar score of less than 9 at five minutes (P>0.05). There was no significant difference between the groups in neonatal heart rate or blood pressure (P>0.05). The umbilical arterial pH level was significantly lower in Group B compared with Group I (P<0.05, Table 2 ). Umbilical venous pH and arterio-venous P a CO 2 , P a O 2 , base excess and lactate levels did not differ (P>0.05, Table 2 ).
DISCUSSION
Spinal anaesthesia is extensively used for deliveries by caesarean section. Maternal hypotension is one of the commonest complications and mild to moderate reduction in maternal blood pressure may have a profound effect on uterine blood flow and fetal wellbeing 10 . Management of hypotension falls into four categories, namely volume expansion, physical methods to increase venous return, prevention or treatment of associated bradycardia and vasoconstriction. However, a more physiological approach to the treatment of hypotension induced by sympathetic block is to prevent its development by administering sympathomimetic drugs 13, 14 . Ephedrine was evaluated by Ralston and coworkers as a vasopressor in the obstetric population in the early 1970s 7 . In animal models (pregnant primates and ewes), direct α-adrenergic agonists have been shown to increase uterine artery resistance, whereas ephedrine has little effect 7 . James and coworkers showed that when pregnant sheep developed hypotension during spinal anaesthesia, ephedrine restored maternal blood pressure, whereas uterine blood flow was not completely restored 15 . Ephedrine is generally accepted as the most appropriate vasopressor for the prevention of maternal hypotension in obstetric anaesthesia. Kang et al 1 have shown that the administration of ephedrine by infusion reduces the incidence of hypotension to as little as 10%. It appears that ephedrine (based on its α-and β-adrenergic activity) affects the venous capacitance system as well as the arteriolar resistance system. Consequently, it restores the blood pressure largely by increasing central venous return and cardiac output 13, 14 . There is, however, no consensus of opinion as to the optimum route or timing of administration. Some studies have failed to demonstrate restoration of blood pressure despite prophylactic infusion of ephedrine 8, 9 while others reported better results with prophylactic infusion 13, 15 . Kang et al 1 compared ephedrine administered by prophylactic bolus or infusion at the time of spinal anaesthesia for caesarean section. They observed no difference between the groups in the dose of ephedrine required, but a higher incidence of nausea and vomiting in the bolus group (36% versus 5%). Our findings were similar.
Datta et al 4 have shown that hypotension has a negative effect on umbilical artery and vein acid-base values. As a result of decreased perfusion in the intervillous space due to hypotension, varying degrees of fetal hypoxia, acidosis, bradycardia and low Apgar scores were observed 4 . Bowe et al 16 reported that the fetal scalp pH correlates with the clinical state of the infant at birth, but another study found no correlation between lactic acidosis and fetal distress or infant pH 12 18 have shown that abnormal fetal heart rate patterns can occur when the duration of maternal systolic blood pressure below 100 mmHg exceeded five minutes. In our study, except for one patient in Group B, none of the parturients had systolic pressure below 100 mmHg for more than three minutes. On the other hand, pH values lower than 7.15 in the umbilical artery might cause an increase in metabolites, which in turn may lead to fetal asphyxia 19 . The umbilical arterial pH values remained in excess of 7.25 in all of our patients. Furthermore no adverse effects were observed in the presence of hypotensive episodes not exceeding three minutes and pH values in excess of 7.25 in healthy women undergoing caesarean section under spinal anaesthesia, even in the presence of moderate hypotension.
When comparing prophylactic infusion of ephedrine with boluses of ephedrine as required, arterial blood pressure was more stable, additional boluses of ephedrine were not necessary, the incidence of nausea and vomiting was markedly reduced and umbilical arterial pH was not lower. We consider therefore, that prophylactic infusion of ephedrine is a superior approach to intermittent bolus dosing of ephedrine as required. However, no alteration in lactate levels was seen despite the observation of marked maternal hypotension (in 13 out of 15 patients) and reduced umbilical arterial pH values in Group B.
